Literature DB >> 27239697

Mannose 6-phosphate-dependent targeting of lysosomal enzymes is required for normal craniofacial and dental development.

Till Koehne1, Sandra Markmann2, Michaela Schweizer3, Nicole Muschol2, Reinhard E Friedrich4, Christian Hagel5, Markus Glatzel5, Bärbel Kahl-Nieke6, Michael Amling7, Thorsten Schinke7, Thomas Braulke8.   

Abstract

Mucolipidosis II (MLII) is a severe systemic genetic disorder caused by defects in mannose 6-phosphate-dependent targeting of multiple lysosomal hydrolases and subsequent lysosomal accumulation of non-degraded material. MLII patients exhibit marked facial coarseness and gingival overgrowth soon after birth, accompanied with delayed tooth eruption and dental infections. To examine the pathomechanisms of early craniofacial and dental abnormalities, we analyzed mice with an MLII patient mutation that mimic the clinical and biochemical symptoms of MLII patients. The mouse data were compared with clinical and histological data of gingiva and teeth from MLII patients. Here, we report that progressive thickening and porosity of calvarial and mandibular bones, accompanied by elevated bone loss due to 2-fold higher number of osteoclasts cause the characteristic craniofacial phenotype in MLII. The analysis of postnatal tooth development by microcomputed tomography imaging and histology revealed normal dentin and enamel formation, and increased cementum thickness accompanied with accumulation of storage material in cementoblasts of MLII mice. Massive accumulation of storage material in subepithelial cells as well as disorganization of collagen fibrils led to gingival hypertrophy. Electron and immunofluorescence microscopy, together with (35)S-sulfate incorporation experiments revealed the accumulation of non-degraded material, non-esterified cholesterol and glycosaminoglycans in gingival fibroblasts, which was accompanied by missorting of various lysosomal proteins (α-fucosidase 1, cathepsin L and Z, Npc2, α-l-iduronidase). Our study shows that MLII mice closely mimic the craniofacial and dental phenotype of MLII patients and reveals the critical role of mannose 6-phosphate-dependent targeting of lysosomal proteins for alveolar bone, cementum and gingiva homeostasis.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cementoblasts; Craniofacial anomalies; Gingival hypertrophy; Lysosomes; Mucolipidosis II; Osteoclastogenesis

Mesh:

Substances:

Year:  2016        PMID: 27239697     DOI: 10.1016/j.bbadis.2016.05.018

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  6 in total

1.  mTORC1 hyperactivation arrests bone growth in lysosomal storage disorders by suppressing autophagy.

Authors:  Rosa Bartolomeo; Laura Cinque; Chiara De Leonibus; Alison Forrester; Anna Chiara Salzano; Jlenia Monfregola; Emanuela De Gennaro; Edoardo Nusco; Isabella Azario; Carmela Lanzara; Marta Serafini; Beth Levine; Andrea Ballabio; Carmine Settembre
Journal:  J Clin Invest       Date:  2017-09-05       Impact factor: 14.808

2.  Dysregulation of mannose-6-phosphate-dependent cholesterol homeostasis in acinar cells mediates pancreatitis.

Authors:  Olga A Mareninova; Eszter T Vegh; Natalia Shalbueva; Carli Jm Wightman; Dustin L Dillon; Sudarshan Malla; Yan Xie; Toshimasa Takahashi; Zoltan Rakonczay; Samuel W French; Herbert Y Gaisano; Fred S Gorelick; Stephen J Pandol; Steven J Bensinger; Nicholas O Davidson; David W Dawson; Ilya Gukovsky; Anna S Gukovskaya
Journal:  J Clin Invest       Date:  2021-08-02       Impact factor: 14.808

3.  Lysosomal Proteome and Secretome Analysis Identifies Missorted Enzymes and Their Nondegraded Substrates in Mucolipidosis III Mouse Cells.

Authors:  Giorgia Di Lorenzo; Renata Voltolini Velho; Dominic Winter; Melanie Thelen; Shiva Ahmadi; Michaela Schweizer; Raffaella De Pace; Kerstin Cornils; Timur Alexander Yorgan; Saskia Grüb; Irm Hermans-Borgmeyer; Thorsten Schinke; Sven Müller-Loennies; Thomas Braulke; Sandra Pohl
Journal:  Mol Cell Proteomics       Date:  2018-05-17       Impact factor: 5.911

4.  Early enzyme replacement therapy prevents dental and craniofacial abnormalities in a mouse model of mucopolysaccharidosis type VI.

Authors:  Rohit Nagpal; Gina Georgi; Sarah Knauth; Carmen Schmid-Herrmann; Nicole Muschol; Thomas Braulke; Bärbel Kahl-Nieke; Michael Amling; Thorsten Schinke; Till Koehne; Julian Petersen
Journal:  Front Physiol       Date:  2022-09-21       Impact factor: 4.755

5.  Deficiency in the endocytic adaptor proteins PHETA1/2 impairs renal and craniofacial development.

Authors:  Kristin M Ates; Tong Wang; Trevor Moreland; Rajalakshmi Veeranan-Karmegam; Manxiu Ma; Chelsi Jeter; Priya Anand; Wolfgang Wenzel; Hyung-Goo Kim; Lynne A Wolfe; Joshi Stephen; David R Adams; Thomas Markello; Cynthia J Tifft; Robert Settlage; William A Gahl; Graydon B Gonsalvez; May Christine Malicdan; Heather Flanagan-Steet; Y Albert Pan
Journal:  Dis Model Mech       Date:  2020-05-26       Impact factor: 5.758

6.  Pathogenic variants in GNPTAB and GNPTG encoding distinct subunits of GlcNAc-1-phosphotransferase differentially impact bone resorption in patients with mucolipidosis type II and III.

Authors:  Giorgia Di Lorenzo; Lena M Westermann; Timur A Yorgan; Julian Stürznickel; Nataniel F Ludwig; Luise S Ammer; Anke Baranowsky; Shiva Ahmadi; Elham Pourbarkhordariesfandabadi; Sandra R Breyer; Tim N Board; Anne Foster; Jean Mercer; Karen Tylee; Renata Voltolini Velho; Michaela Schweizer; Thomas Renné; Thomas Braulke; Dévora N Randon; Fernanda Sperb-Ludwig; Louise Lapagesse de Camargo Pinto; Carolina Araujo Moreno; Denise P Cavalcanti; Michael Amling; Kerstin Kutsche; Dominic Winter; Nicole M Muschol; Ida V D Schwartz; Tim Rolvien; Tatyana Danyukova; Thorsten Schinke; Sandra Pohl
Journal:  Genet Med       Date:  2021-08-02       Impact factor: 8.822

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.